XBiotech Quote - XBIT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.46

Bid

3.26

Offer

4.50

Volume

55,038

3.44 Day's Range 3.69

3.40 52 Week Range 9.96

Market Cap

105.473M

Previous Close

3.62

Open

3.68

Last Trade

3.41

Last Trade Time

Financial Volume

US$ 196,361

VWAP

3.5677

Average Volume (3m)

70,126

Shares Outstanding

30,483,481

Dividend Yield

PE Ratio

-3.24

Earnings Per Share (EPS)

-1.08

Revenue

4.01M

Net Profit

-32.9M

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xbiotech.com

Headquarters

Austin, Texas, USA

Founded

XBiotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XBIT. The last closing price for XBiotech was US$3.62. Over the last year, XBiotech shares have traded in a share price range of US$ 3.40 to US$ 9.96.

XBiotech currently has 30,483,481 shares in issue. The market capitalisation of XBiotech is US$110.35 million. XBiotech has a price to earnings ratio (PE ratio) of -3.24.

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.26	-6.98924731183	3.72	3.78	3.4	45433	3.58892408	CS
4	-0.77	-18.2033096927	4.23	4.67	3.4	53704	3.9264916	CS
12	-3.96	-53.3692722372	7.42	7.7399	3.4	70126	5.45304934	CS
26	-3.98	-53.4946236559	7.44	8.32	3.4	58040	6.17095388	CS
52	-0.86	-19.9074074074	4.32	9.96	3.4	72470	6.61938403	CS
156	-6.94	-66.7307692308	10.4	10.96	3	61076	5.96416099	CS
260	-19.06	-84.6358792185	22.52	25.8	3	102829	12.38742071	CS

XBIT - Frequently Asked Questions (FAQ)

What is the current XBiotech share price?

The current share price of XBiotech is US$ 3.46

How many XBiotech shares are in issue?

XBiotech has 30,483,481 shares in issue

What is the market cap of XBiotech?

The market capitalisation of XBiotech is USD 110.35M

What is the 1 year trading range for XBiotech share price?

XBiotech has traded in the range of US$ 3.40 to US$ 9.96 during the past year

What is the PE ratio of XBiotech?

The price to earnings ratio of XBiotech is -3.24

What is the cash to sales ratio of XBiotech?

The cash to sales ratio of XBiotech is 26.62

What is the reporting currency for XBiotech?

XBiotech reports financial results in USD

What is the latest annual turnover for XBiotech?

The latest annual turnover of XBiotech is USD 4.01M

What is the latest annual profit for XBiotech?

The latest annual profit of XBiotech is USD -32.9M

What is the registered address of XBiotech?

The registered address for XBiotech is 5217 WINNEBAGO LN, AUSTIN, TX 78744, AUSTIN, TEXAS, 78744

What is the XBiotech website address?

The website address for XBiotech is www.xbiotech.com

Which industry sector does XBiotech operate in?

XBiotech operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M

Symbol

Price

Vol.